Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Recruiting
N/A
Interventional Study
Stem Cell Transplant Complications
Sleep Disturbance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 9 – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 10 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). Th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient aged 9-17 years.
* Patient scheduled to receive a stem cell transplant at Boston Children's Hospital.
* English speaking child and primary caregiver (parent/guardian).
Exclusion Criteria:
-Primary team declines permission to approach.
Contacts
Eric Zhou, PhD
617-632-6162
CONTACT